Neuroellan-LC is used for diabetic peripheral neuropathy, idiopathic neuropathy, chemotherapy-induced neuropathy, alcoholic neuropathy, and other peripheral nerve disorders
In this regard, GLP1 receptor drugs can be subdivided pharmacologically by their duration of action into shortacting and longacting classes (Aroda, 2018)
Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al
Dosage Forms and Strengths Injection: 6 mg/mL clear, colorless solution in a 3 mL prefilled, single-patient-use pen that delivers doses of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg, or 3 mg
Efficacy Concerns : When tirzepatide freezes, the primary risk is reduced effectiveness rather than the medication becoming dangerous or harmful
If you weigh 180 lbs (82 kg), that's roughly 100-130g of protein daily